How have HSTO shares performed in 2024?

Histogen's stock was trading at $0.3077 at the beginning of 2024. Since then, HSTO shares have increased by 62.5% and is now trading at $0.50. View the best growth stocks for 2024 here .

How were Histogen's earnings last quarter?

Histogen Inc. (NASDAQ:HSTO) announced its quarterly earnings results on Wednesday, November, 10th. The company reported ($1.80) earnings per share for the quarter, topping the consensus estimate of ($2.20) by $0.40. The company had revenue of $0.59 million for the quarter. Histogen had a negative net margin of 65,142.11% and a negative trailing twelve-month return on equity of 136.13%. During the same period in the prior year, the firm earned ($5.40) EPS.

When did Histogen's stock split?

Shares of Histogen reverse split before market open on Friday, June 3rd 2022. The 1-20 reverse split was announced on Friday, June 3rd 2022. The number of shares owned by shareholders was adjusted after the closing bell on Friday, June 3rd 2022. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

What other stocks do shareholders of Histogen own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Histogen investors own include Carnival Co. & (CCL) , Intel (INTC) , Genius Brands International (GNUS) , Gilead Sciences (GILD) , Clovis Oncology (CLVS) , B2Gold (BTG) , BIOLASE (BIOL) , (BBI.V) (BBI) , Advanced Micro Devices (AMD) and Akers Biosciences (AKER) .

How do I buy shares of Histogen?

Shares of HSTO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:HSTO

Histogen (HSTO) Stock Price, News & Analysis

→ A.I. “Perfect Storm” Could Send THESE Stocks Sky High (From InvestorPlace) (Ad)

Free HSTO Stock Alerts

$0.50

0.00 (0.00%)

(As of 04/15/2024 ET)

Compare

Today's Range: $0.50
▼
$0.50
50-Day Range: $0.32
▼
$0.50
52-Week Range: $0.28
▼
$1.22

Volume: 4,532 shs
Average Volume: 22,447 shs
Market Capitalization: $2.14 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Chart Competitors Earnings Financials Headlines SEC Filings Social Media

Get Histogen alerts:

Ad InvestorPlace

“Forget Tesla, this is Elon’s Next Big Thing”

According to Forbes, this breakthrough could define the future of AI. Most people don’t know about it… Because it was found 750 miles away from Silicon Valley.

Click here to see the details.

About Histogen Stock (NASDAQ:HSTO)

Histogen Inc., a clinical-stage therapeutics company, focuses on developing clinical and preclinical small molecule pan-caspase and caspase selective inhibitors that protect the body's natural process to restore immune function. The company's product candidates include emricasan for the treatment of acute bacterial skin and skin structure infections, as well as other infectious diseases. Its preclinical product candidates include CTS-2090 and CTS-2096, which are selective small molecule inhibitors of caspase-1 designed for the treatment of various inflammatory diseases. Histogen Inc. was founded in 2007 and is based in San Diego, California.

HSTO Stock Price History

30 days | 90 days | 365 days | Advanced Chart

HSTO Stock News Headlines

February 6, 2024 | benzinga.com

Histogen Stock (OTC:HSTO) Dividends: History, Yield and Dates

December 14, 2023 | finance.yahoo.com

Histogen Announces Second Adjournment of Special Meeting of Stockholders

April 16, 2024 | InvestorPlace (Ad)

Elon Musk’s ChatGPT Could Soon Mint New Millionaires

Elon Musk made $180 million on PayPal… $47 Billion on SpaceX…and $94.2 Billion on Tesla. He’s about to shock the world again with his version of ChatGPT.

December 6, 2023 | finanznachrichten.de

Histogen Inc: Histogen Announces Adjournment of Special Meeting of Stockholders

December 5, 2023 | finance.yahoo.com

Histogen Announces Adjournment of Special Meeting of Stockholders

November 1, 2023 | morningstar.com

Histogen Inc HSTO

September 21, 2023 | msn.com

Wall Street Set to Open Wednesday Trading Higher as Investors Await Fed Decision on Interest Rates

September 20, 2023 | msn.com

U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.31%

April 16, 2024 | InvestorPlace (Ad)

Elon Musk’s ChatGPT Could Soon Mint New Millionaires

Elon Musk made $180 million on PayPal… $47 Billion on SpaceX…and $94.2 Billion on Tesla. He’s about to shock the world again with his version of ChatGPT.

September 20, 2023 | finanznachrichten.de

Histogen Inc: Histogen Announces Board Approval of Complete Liquidation and Dissolution

September 20, 2023 | markets.businessinsider.com

Histogen Board Approves To Dissolve And Wind Down Operations

September 19, 2023 | msn.com

U.S. shares lower at close of trade; Dow Jones Industrial Average down 0.31%

September 18, 2023 | msn.com

Biotech firm Histogen to wind down after failing to raise capital

September 18, 2023 | finance.yahoo.com

Histogen Announces Board Approval of Complete Liquidation and Dissolution

July 6, 2023 | benzinga.com

Histogen shares are trading higher after the company decided to pause further development of its programs, commence exploring strategic alternatives.

July 5, 2023 | seekingalpha.com

Histogen plans to commence strategic alternatives process

July 5, 2023 | finance.yahoo.com

Histogen to Explore Strategic Alternatives

May 11, 2023 | finance.yahoo.com

Histogen Reports First Quarter 2023 Results and Provides Business Update

April 20, 2023 | finance.yahoo.com

Histogen Announces Online Publication in the Journal of Investigative Dermatology

April 3, 2023 | finance.yahoo.com

Histogen Announces Exclusive Intellectual Property License Agreement with Johns Hopkins University

March 20, 2023 | benzinga.com

Short Volatility Alert: Histogen Inc

March 17, 2023 | investorplace.com

Why Is Histogen (HSTO) Stock Up 37% Today?

March 16, 2023 | finance.yahoo.com

Histogen Announces Issuance of US Patent Covering CTS-2090 Methods of Use

March 9, 2023 | finance.yahoo.com

Histogen Reports Year-End 2022 Results and Provides Business Update

February 27, 2023 | finance.yahoo.com

Histogen Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

January 15, 2023 | finance.yahoo.com

Histogen (HSTO) Upgraded to Strong Buy: Here's What You Should Know

January 3, 2023 | finance.yahoo.com

Histogen Hires Alfred P. Spada Ph.D. as Executive Vice President and Chief Scientific Officer

See More Headlines

Receive HSTO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Histogen and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 11/10/2021
Today: 4/16/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Pharmaceutical preparations
Sub-Industry: N/A
Current Symbol: NASDAQ:HSTO
CUSIP: N/A
CIK: 1383701
Web: www.histogen.com
Phone: (858) 526-3100
Fax: N/A
Employees: 7
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): ($2.81)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-10,620,000.00
Net Margins: -65,142.11%
Pretax Margin: -65,178.96%
Return on Equity: -136.13%
Return on Assets: -90.87%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 4.05
Quick Ratio: 4.05

Sales & Book Value

Annual Sales: $3.77 million
Price / Sales: 0.57
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $3.13 per share
Price / Book: 0.16

Miscellaneous

Outstanding Shares: 4,270,000
Free Float: 4,131,000
Market Cap: $2.14 million
Optionable: Not Optionable
Beta: 0.92

12 Stocks Corporate Insiders are Abandoning

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Key Executives

Ms. Susan A. Knudson (Age 60)
President, CEO, CFO, COO, Chief Compliance Officer & Corporate Secretary
Comp: $653.2k

Key Competitors

View All Competitors

HSTO Stock Analysis - Frequently Asked Questions

How have HSTO shares performed in 2024?: Histogen's stock was trading at $0.3077 at the beginning of 2024. Since then, HSTO shares have increased by 62.5% and is now trading at $0.50.
View the best growth stocks for 2024 here.
How were Histogen's earnings last quarter?: Histogen Inc. (NASDAQ:HSTO) announced its quarterly earnings results on Wednesday, November, 10th. The company reported ($1.80) earnings per share for the quarter, topping the consensus estimate of ($2.20) by $0.40. The company had revenue of $0.59 million for the quarter. Histogen had a negative net margin of 65,142.11% and a negative trailing twelve-month return on equity of 136.13%. During the same period in the prior year, the firm earned ($5.40) EPS.
When did Histogen's stock split?: Shares of Histogen reverse split before market open on Friday, June 3rd 2022. The 1-20 reverse split was announced on Friday, June 3rd 2022. The number of shares owned by shareholders was adjusted after the closing bell on Friday, June 3rd 2022. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

What other stocks do shareholders of Histogen own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Histogen investors own include Carnival Co. & (CCL), Intel (INTC), Genius Brands International (GNUS), Gilead Sciences (GILD), Clovis Oncology (CLVS), B2Gold (BTG), BIOLASE (BIOL), (BBI.V) (BBI), Advanced Micro Devices (AMD) and Akers Biosciences (AKER).
How do I buy shares of Histogen?: Shares of HSTO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:HSTO) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial